Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Aveanna Healthcare stock jumped 23%, but a major fund still sold $16 million of AVAH shares. This article breaks down...
A seismic shift is brewing in the card world. Capital One's integration with Discover could turn payment processing i...
AMD has surged dramatically, up 320% over the past year, sparking questions about whether investors should shift focu...
As volatility returns, smart investors ask which asset will shield wealth the best. This guide compares gold, silver,...
Lucid’s stock once rode a wave of excitement in the EV space, but it has cooled dramatically. This guide breaks down ...
In a historic U.S. mortgage milestone, Coinbase and Better Home & Finance launch the first conforming crypto-backed p...
Perella Weinberg stock lags the broader market, even as a major fund just boosted its stake by about $15 million. Thi...
Meta Platforms unveils a record AI data center push, signaling a major shift in capital allocation. The stock's next ...
Retirement success goes beyond money. By nurturing social bonds, you can boost happiness, longevity, and financial co...
Want real estate exposure without being a landlord? This lazy investor’s guide real explores how syndications let you...
A former lululemon executive voices governance concerns, highlighting how board independence, capital allocation, and...